Weekly report on share repurchases from 17th November to 21st November 2025
Name of the Issuer
Identify code of the Issuer
Transaction day
Identify code of the financial instrument
Total daily volume (in number of shares)
Daily weighted average purchase price of
the shares
Market (MIC
Code)
EUROFINS SCIENTIFIC
529900JEHFM47DYY3S57
17/11/2025
FR0014000MR3
20 000
58.7743
XPAR
EUROFINS SCIENTIFIC
529900JEHFM47DYY3S57
18/11/2025
FR0014000MR3
20 000
57.7048
XPAR
EUROFINS SCIENTIFIC
529900JEHFM47DYY3S57
19/11/2025
FR0014000MR3
20 000
57.8022
XPAR
EUROFINS SCIENTIFIC
529900JEHFM47DYY3S57
20/11/2025
FR0014000MR3
20 000
57.7432
XPAR
EUROFINS SCIENTIFIC
529900JEHFM47DYY3S57
21/11/2025
FR0014000MR3
25 000
57.6295
XPAR
TOTAL
105 000
57.9165
Transaction details
In accordance with Article 5(1)(b) of Regulation (EU) N° 596/2014 (the Market Abuse Regulation) a full breakdown of the individual trades are disclosed on Eurofins Scientific SE website: https://www.eurofins.com/investors/share-buy-back-programmes
Attachments
Original document
Permalink
Disclaimer
Eurofins Scientific SE published this content on November 24, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on November 24, 2025 at 18:11 UTC.
Eurofins Scientific SE is one of the world's leading providers of bio-analytical services. The group's services are intended to validate the safety, authenticity, origin, identity, and purity of biological substances contained in the environment (water, air, soil, etc.) and in food, pharmaceutical, cosmetic, and hygiene products.
At the end of 2024, Eurofins Scientific SE owned a portfolio of over 200,000 analytical methods and had 950 laboratories located throughout the world.
Net sales are distributed geographically as follows: Europe (51%), North America (38.3%) and other (10.7%).
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
